VC
ABBV icon

Veracity Capital’s AbbVie ABBV Stock Holding History

Veracity Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.24M Buy
4,735
+221
+5% +$56.7K 0.33% 49
2026
Q2 		$1.14M Sell
4,514
-60
-1% -$12.9K 0.31% 62
2026
Q1 		$995K Sell
4,574
-296
-6% -$65.7K 0.36% 52
2025
Q4 		$1.11M Sell
4,870
-4
-0.1% -$911 0.33% 53
2025
Q3 		$1.13M Buy
4,874
+1,408
+41% +$287K 0.36% 53
2025
Q2 		$643K Sell
3,466
-666
-16% -$124K 0.22% 103
2025
Q1 		$866K Sell
4,132
-550
-12% -$107K 0.34% 65
2024
Q4 		$832K Buy
4,682
+338
+8% +$62.1K 0.3% 71
2024
Q3 		$858K Sell
4,344
-22
-0.5% -$4.11K 0.33% 61
2024
Q2 		$749K Sell
4,366
-939
-18% -$156K 0.31% 64
2024
Q1 		$966K Sell
5,305
-335
-6% -$57.7K 0.38% 57
2023
Q4 		$874K Buy
5,640
+170
+3% +$24.8K 0.35% 58
2023
Q3 		$815K Buy
5,470
+233
+4% +$34.2K 0.38% 55
2023
Q2 		$706K Sell
5,237
-78
-1% -$11.4K 0.3% 78
2023
Q1 		$847K Sell
5,315
-70
-1% -$10.7K 0.39% 53
2022
Q4 		$870K Buy
5,385
+52
+1% +$7.97K 0.42% 53
2022
Q3 		$716K Buy
5,333
+189
+4% +$27.1K 0.39% 56
2022
Q2 		$788K Sell
5,144
-2
-0% -$306 0.42% 54
2022
Q1 		$834K Buy
5,146
+1,536
+43% +$223K 0.35% 65
2021
Q4 		$489K Buy
3,610
+196
+6% +$23.2K 0.2% 128
2021
Q3 		$368K Sell
3,414
-43,371
-93% -$4.96M 0.16% 147
2021
Q2 		$5.21M Buy
46,785
+43,467
+1,310% +$4.9M 1.21% 16
2021
Q1 		$359K Buy
3,318
+366
+12% +$39.1K 0.16% 152
2020
Q4 		$316K Sell
2,952
-1,103
-27% -$106K 0.16% 154
2020
Q3 		$355K Sell
4,055
-9,663
-70% -$910K 0.2% 123
2020
Q2 		$1.35M Sell
13,718
-12,209
-47% -$1.07M 0.78% 25
2020
Q1 		$1.98M Buy
25,927
+21,751
+521% +$1.85M 0.57% 41
2019
Q4 		$370K Buy
+4,176
New +$347K 0.1% 158

Other funds holding ABBV

HCM
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $880M AUM 10.53% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Veracity Capital's ABBV Position: Q3 2026 in Review

Veracity Capital increased its AbbVie (ABBV) stake by 4.9% in Q3 2026, buying an estimated $56.7K and bringing the position to 4,735 shares worth $1.24M. The position accounts for 0.33% of the portfolio, ranked #49.

Veracity Capital first reported a position in ABBV in Q4 2019 and has held it in 28 quarters since. The position peaked at $5.21M in Q2 2021. 246 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Veracity Capital held 4,735 shares of AbbVie worth $1.24M as of Q3 2026.
  • Veracity Capital bought 221 AbbVie shares in Q3 2026, an estimated $56.7K.
  • AbbVie made up 0.33% of Veracity Capital's portfolio in Q3 2026, its #49 holding.
  • Veracity Capital first reported a position in AbbVie in Q4 2019 and has held it in 28 quarters since.
  • Veracity Capital's AbbVie position peaked at $5.21M in Q2 2021.
  • 246 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Veracity Capital's 13F filing for Q3 2026, filed 8 Oct 2026.